Cardiovascular news

NICE updates chronic heart failure guideline

NICE updates chronic heart failure guideline

NICE has updated its guideline on chronic heart failure...

Low-dose aspirin 'ineffective' for cardiovascular prevention in larger patients

Low-dose aspirin 'ineffective' for cardiovascular prevention in larger patients

Higher aspirin doses may be needed to prevent vascular...

Prescribing antihypertensive drugs as a single pill 'leads to better outcomes'

Prescribing antihypertensive drugs as a single pill 'leads to better outcomes'

Patients prescribed a combination of antihypertensive...

New MIMS table summarises monitoring requirements for lipid-lowering drugs

New MIMS table summarises monitoring requirements for lipid-lowering drugs

GPs can now use a handy MIMS table to check which tests...

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

PCSK9 inhibitor licensed for risk reduction in established cardiovascular disease

Repatha (evolocumab) can now be prescribed to reduce...

New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention

New MIMS table summarises dosing of novel oral anticoagulants for stroke prevention

GPs can now consult a handy MIMS table to help them...

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

GPs should no longer prescribe 18 'low value' treatments, NHS England rules

NHS England believes cutting access to the treatments,...

Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises

Prescribe quinine with caution in patients at risk of QT prolongation, MHRA advises

New advice highlights that quinine can have effects...

Warfarin interaction warning for miconazole oral gel

Warfarin interaction warning for miconazole oral gel

Miconazole oral gel should be prescribed with caution...

Stopping statins after stroke linked to higher risk of recurrent stroke

Stopping statins after stroke linked to higher risk of recurrent stroke

Patients who stop statin therapy 3 to 6 months after...

Anticoagulant linked to rare calciphylaxis risk

Anticoagulant linked to rare calciphylaxis risk

Calciphylaxis, a rare but serious condition causing...

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Selexipag: new class of treatment for pulmonary artery hypertension reaches prescribers

Uptravi (selexipag), a prostacyclin receptor agonist...

NICE approval for new class of lipid-lowering drugs

NICE approval for new class of lipid-lowering drugs

NHS clinicians must now have the option to prescribe...

Update: GPs warned about error in cardiovascular risk calculator

Update: GPs warned about error in cardiovascular risk calculator

GPs have been advised not to use the QRISK2 cardiovascular...

'Innovative' heart failure treatment approved by NICE

'Innovative' heart failure treatment approved by NICE

A new type of drug to treat heart failure, which could...

Ticagrelor approved for long-term treatment following MI

Ticagrelor approved for long-term treatment following MI

The antiplatelet treatment Brilique (ticagrelor) can...

New once-daily fibrate/statin combination

New once-daily fibrate/statin combination

Prescribers now have the option to prescribe fenofibrate...

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetimibe licensed to reduce the risk of cardiovascular events

Ezetrol (ezetimibe) can now be prescribed to reduce...

Spironolactone hyperkalaemia warning over co-administration

Spironolactone hyperkalaemia warning over co-administration

Monitoring of blood electrolytes is essential when...

First reversal agent available for non-coumarin oral anticoagulant

First reversal agent available for non-coumarin oral anticoagulant

Idarucizumab (Praxbind) rapidly reverses the anticoagulant...